HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis
- 10 September 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (41), 16568-16573
- https://doi.org/10.1073/pnas.1308755110
Abstract
In women, estrogen deficiency after menopause frequently accelerates osteoclastic bone resorption, leading to osteoporosis, the most common skeletal disorder. However, mechanisms underlying osteoporosis resulting from estrogen deficiency remain largely unknown. Here we show that in bone-resorbing osteoclasts, estrogen-dependent destabilization of hypoxia-inducible factor 1 alpha (HIF1α), which is unstable in the presence of oxygen, plays a pivotal role in promoting bone loss in estrogen-deficient conditions. In vitro, HIF1α was destabilized by estrogen treatment even in hypoxic conditions, and estrogen loss in ovariectomized (Ovx) mice stabilized HIF1α in osteoclasts and promoted their activation and subsequent bone loss in vivo. Osteoclast-specific HIF1α inactivation antagonized bone loss in Ovx mice and osteoclast-specific estrogen receptor alpha deficient mice, both models of estrogen-deficient osteoporosis. Oral administration of a HIF1α inhibitor protected Ovx mice from osteoclast activation and bone loss. Thus, HIF1α represents a promising therapeutic target in osteoporosis.This publication has 27 references indexed in Scilit:
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionNature Reviews Cancer, 2011
- The Blimp1–Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasisThe Journal of Experimental Medicine, 2010
- HIF-1 regulation: not so easy come, easy goTrends in Biochemical Sciences, 2008
- Vascular endothelial growth factor-A is a survival factor for nucleus pulposus cells in the intervertebral discBiochemical and Biophysical Research Communications, 2008
- Hypoxia: A key regulator of angiogenesis in cancerCancer and Metastasis Reviews, 2007
- The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal developmentJCI Insight, 2007
- DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cellsThe Journal of Experimental Medicine, 2005
- Molecular Determinants for the Tissue Specificity of SERMsScience, 2002
- Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?Endocrine Reviews, 1999